JIANGSU HENGRUI Medicine CO LTD

General

Total Cases2

Active Cases1

Patents--

CourtsD. Delaware D. New Jersey

TypeOperating Company

Elite Ratings

--

jiangsu-hengrui

jiangsu-hengrui

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/19/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	Letter from E. Abraham to Judge Almonte requesting a two week extension to file a Motion to Seal. (ABRAHAM, ERIC) (Entered: 09/19/2024)
09/19/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	Letter from All Parties re Samples re 138 Text Order,,. (BETZ, CYNTHIA) (Entered: 09/19/2024)
09/11/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	STIPULATION and Proposed Order to Stay by PACIRA BIOSCIENCES, INC., PACIRA PHARMACEUTICALS, INC.. (BETZ, CYNTHIA) (Entered: 09/11/2024)
09/09/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	TEXT ORDER: As discussed during the September 6, 2024 conference, by September 11, 2024, the parties shall submit a proposed order regarding their consent to stay the 23-cv-02367 case. By no later than September 20, 2024, the parties shall meet and confer and file a joint letter. In that letter, Plaintiffs shall detail their efforts to test the Chinese Product samples. See ECF No. [106] . In the same letter, all parties may further supplement their position on whether the 24-cv-06294 and 24-cv-07680 cases should be consolidated. So Ordered by Magistrate Judge Jose R. Almonte on 9/6/2024. (akw, ) (Entered: 09/09/2024) TEXT ORDER: As discussed during the September 6, 2024 conference, by September 11, 2024, the parties shall submit a proposed order regarding their consent to stay the 23-cv-02367 case. By no later than September 20, 2024, the parties shall meet and confer and file a joint letter. In that letter, Plaintiffs shall detail their efforts to test the Chinese Product samples. See ECF No. [106] . In the same letter, all parties may further supplement their position on whether the 24-cv-06294 and 24-cv-07680 cases should be consolidated. So Ordered by Magistrate Judge Jose R. Almonte on 9/6/2024. (akw, ) (Entered: 09/09/2024)
09/09/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	TEXT ORDER: As discussed during the September 6, 2024 conference, by September 11, 2024, the parties shall submit a proposed order regarding their consent to stay the 23-cv-02367 case. By no later than September 20, 2024, the parties shall meet and confer and file a joint letter. In that letter, Plaintiffs shall detail their efforts to test the Chinese Product samples. See ECF No. 106 . In the same letter, all parties may further supplement their position on whether the 24-cv-06294 and 24-cv-07680 cases should be consolidated. So Ordered by Magistrate Judge Jose R. Almonte on 9/6/2024. (akw, ) (Entered: 09/09/2024) TEXT ORDER: As discussed during the September 6, 2024 conference, by September 11, 2024, the parties shall submit a proposed order regarding their consent to stay the 23-cv-02367 case. By no later than September 20, 2024, the parties shall meet and confer and file a joint letter. In that letter, Plaintiffs shall detail their efforts to test the Chinese Product samples. See ECF No. 106 . In the same letter, all parties may further supplement their position on whether the 24-cv-06294 and 24-cv-07680 cases should be consolidated. So Ordered by Magistrate Judge Jose R. Almonte on 9/6/2024. (akw, ) (Entered: 09/09/2024)
09/09/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	Minute Entry for proceedings held before Magistrate Judge Jose R. Almonte. A status conference was held on September 6, 2024. During the conference, the Court addressed the parties' letter dated August 23, 2024 (ECF No. 133 in Case No. 23-02367). (akw, ) (Entered: 09/09/2024)
09/06/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	LETTER ORDER granting 136 request for a two-week extension of Defendants' deadline to file a motion to seal the August 23, 2024 letter (ECF No. 133 in Civil Action No. 23-02367). Signed by Magistrate Judge Jose R. Almonte on 9/6/2024. (ld, ) (Entered: 09/06/2024)
09/05/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	Letter from E. Abraham to Judge Almonte requesting a two week extension to file a Motion to Seal re 133 Letter,,. (ABRAHAM, ERIC) (Entered: 09/05/2024)
09/03/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	TEXT ORDER: TEXT ORDER: TIME CHANGE ONLY. The videoconference set for September 6, 2024, is scheduled for 11:00 a.m. So Ordered by Magistrate Judge Jose R. Almonte on 9/3/2024. (akw) (Entered: 09/03/2024)
09/03/24	Pacira Pharmaceuticals Inc v. Evenus Pharmaceuticals Laboratories Inc 2:23-CV-02367 ( D. NJ )	TEXT ORDER: The Court is in receipt of the parties' August 23, 2024 letter (ECF No. [133] in Case No. 23-cv-02367, ECF No. [12] in Case No. 24-cv-07680, and ECF No. [23] in Case No. 24-cv-06294). A conference will be held by videoconferencing on September 6, 2024, at 10:00 a.m. The Court will provide videoconferencing information in advance. So Ordered by Magistrate Judge Jose R. Almonte on 8/29/2024. (akw) (Entered: 09/03/2024) TEXT ORDER: The Court is in receipt of the parties' August 23, 2024 letter (ECF No. [133] in Case No. 23-cv-02367, ECF No. [12] in Case No. 24-cv-07680, and ECF No. [23] in Case No. 24-cv-06294). A conference will be held by videoconferencing on September 6, 2024, at 10:00 a.m. The Court will provide videoconferencing information in advance. So Ordered by Magistrate Judge Jose R. Almonte on 8/29/2024. (akw) (Entered: 09/03/2024)